Structural biology of dengue virus enzymes

Towards rational design of therapeutics

Christian G. Noble, Pei-Yong Shi

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Development of anti-dengue therapy represents an urgent un-met medical need. Towards antiviral therapy, recent advances in crystal structures of DENV enzymes have led to the possibility of structure-based rational design of inhibitors for anti-dengue therapy. These include (i) the structure of the 'active' form of the DENV protease in complex with a peptide substrate; (ii) the structure of DENV methyltransferase bound to an inhibitor that selectively suppresses viral methyltransferase, but not human methyltransferases; (iii) the structure of DENV RNA-dependent RNA polymerase in complex with a small-molecule compound. This review summarizes the structural biology of these three key enzymes (protease, methyltransferase, and polymerase) that are essential for DENV replication. The new structural information has provided new avenues for development of anti-dengue therapy.

Original languageEnglish (US)
Pages (from-to)115-126
Number of pages12
JournalAntiviral Research
Volume96
Issue number2
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Dengue Virus
Methyltransferases
Dengue
Enzymes
Peptide Hydrolases
RNA Replicase
Therapeutics
Antiviral Agents
Peptides

Keywords

  • Crystal structure
  • Dengue virus
  • Enzyme
  • Flavivirus
  • Structure-based design

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Structural biology of dengue virus enzymes : Towards rational design of therapeutics. / Noble, Christian G.; Shi, Pei-Yong.

In: Antiviral Research, Vol. 96, No. 2, 11.2012, p. 115-126.

Research output: Contribution to journalArticle

@article{7e4aa1f2509c49e6bf780d2707827469,
title = "Structural biology of dengue virus enzymes: Towards rational design of therapeutics",
abstract = "Development of anti-dengue therapy represents an urgent un-met medical need. Towards antiviral therapy, recent advances in crystal structures of DENV enzymes have led to the possibility of structure-based rational design of inhibitors for anti-dengue therapy. These include (i) the structure of the 'active' form of the DENV protease in complex with a peptide substrate; (ii) the structure of DENV methyltransferase bound to an inhibitor that selectively suppresses viral methyltransferase, but not human methyltransferases; (iii) the structure of DENV RNA-dependent RNA polymerase in complex with a small-molecule compound. This review summarizes the structural biology of these three key enzymes (protease, methyltransferase, and polymerase) that are essential for DENV replication. The new structural information has provided new avenues for development of anti-dengue therapy.",
keywords = "Crystal structure, Dengue virus, Enzyme, Flavivirus, Structure-based design",
author = "Noble, {Christian G.} and Pei-Yong Shi",
year = "2012",
month = "11",
doi = "10.1016/j.antiviral.2012.09.007",
language = "English (US)",
volume = "96",
pages = "115--126",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Structural biology of dengue virus enzymes

T2 - Towards rational design of therapeutics

AU - Noble, Christian G.

AU - Shi, Pei-Yong

PY - 2012/11

Y1 - 2012/11

N2 - Development of anti-dengue therapy represents an urgent un-met medical need. Towards antiviral therapy, recent advances in crystal structures of DENV enzymes have led to the possibility of structure-based rational design of inhibitors for anti-dengue therapy. These include (i) the structure of the 'active' form of the DENV protease in complex with a peptide substrate; (ii) the structure of DENV methyltransferase bound to an inhibitor that selectively suppresses viral methyltransferase, but not human methyltransferases; (iii) the structure of DENV RNA-dependent RNA polymerase in complex with a small-molecule compound. This review summarizes the structural biology of these three key enzymes (protease, methyltransferase, and polymerase) that are essential for DENV replication. The new structural information has provided new avenues for development of anti-dengue therapy.

AB - Development of anti-dengue therapy represents an urgent un-met medical need. Towards antiviral therapy, recent advances in crystal structures of DENV enzymes have led to the possibility of structure-based rational design of inhibitors for anti-dengue therapy. These include (i) the structure of the 'active' form of the DENV protease in complex with a peptide substrate; (ii) the structure of DENV methyltransferase bound to an inhibitor that selectively suppresses viral methyltransferase, but not human methyltransferases; (iii) the structure of DENV RNA-dependent RNA polymerase in complex with a small-molecule compound. This review summarizes the structural biology of these three key enzymes (protease, methyltransferase, and polymerase) that are essential for DENV replication. The new structural information has provided new avenues for development of anti-dengue therapy.

KW - Crystal structure

KW - Dengue virus

KW - Enzyme

KW - Flavivirus

KW - Structure-based design

UR - http://www.scopus.com/inward/record.url?scp=84867236960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867236960&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2012.09.007

DO - 10.1016/j.antiviral.2012.09.007

M3 - Article

VL - 96

SP - 115

EP - 126

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -